PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.\', \'SSD Clinical Pharmacology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.\', \'Department of Systems Medicine, University of Rome \'Tor Vergata\', Rome, Italy.\', \'Infectious Diseases Clinic, University Hospital \'Tor Vergata\', Rome, Italy.\', \'Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2147/DDDT.S313756
?:hasPublicationType
?:journal
  • Drug design, development and therapy
is ?:pmid of
?:pmid
?:pmid
  • 34376971
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.974
?:rankingScore_hIndex
  • 40
is ?:relation_isRelatedTo_publication of
?:title
  • Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34376971>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34376971>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all